Barry Berman
Write a Review

Barry Berman, MD, MS

Board-certified in medical oncology, hematology, and internal medicine, Dr. Berman earned his medical degree from the University of South Florida College of Medicine, received his internal medicine training at the University of South Florida, and completed his fellowship in medical oncology and hematology at the University of South Florida, H. Lee Moffitt Cancer Center.

Serving many years as a board member for the Florida Society of Clinical Oncology (FLASCO), Dr. Berman also held positions as Clinical Practice Committee Chair, Vice President, Secretary and Treasurer for FLASCO. He has also served on the American Society of Clinical Oncology (ASCO) Practice Guideline Implementation Network (PGIN) Committee since 2015 and was an author on three of the current guidelines. He also served as chair of the Investigational Review Board at Broward Health.

As a cancer researcher, Dr. Berman has been actively engaged in multiple clinical studies over the last 25 years and has been published in many peer-reviewed journals.

In his spare time, Dr. Berman enjoys photography, traveling, spending time with his family, and teaching his miniature Australian Shepard new tricks.

Treatments Provided
  • Hematology
  • Medical Oncology
Languages Spoken
  • English

Medical School

  • University of South Florida – Tampa, FL


  • University of South Florida – Tampa, FL


  • Medical Oncology/Hematology – University of South Florida/H. Lee Moffitt Cancer Center – Tampa, FL

Board Certified

  • Medical Oncology
  • Hematology
  • Internal Medicine

Professional Affiliations

  • American Society of Clinical Oncology (ASCO)
  • ASCO Practice Guideline Implementation Network (PGIN), Committee Member
  • Florida Society of Clinical Oncology (FLASCO), Secretary
  • American Medical Association
  • American Society of Internal Medicine
  • American College of Physicians
  • Southern Association of Oncology


Colon Cancer Facts with FCS Medical Oncologist Barry Berman, MD, MS

In the United States, Colon cancer affects 1 in 23 men – nearly 5% of all men are at risk of developing this disease in their lifetime. The availability of effective early screening and the ease of making lifestyle changes improve the outlook. In recognition of Men’s Health Month, Florida Cancer Specialists medical oncologist Dr. Barry Berman joins the conversation to help raise awareness and understanding of this disease.

Prostate Cancer Risks & Treatment Options – FCS medical oncologists Drs. Barry Berman and Mahdi Taha

One in eight American males will be diagnosed with prostate cancer in their lifetime, so it’s important to know the facts. Florida Cancer Specialists medical oncologists Dr. Barry Berman and Dr. Mahdi Taha discuss who is most at risk and the recommended screenings, as well as the individualized treatments available. FCS offers clinical trials as an added option for achieving the best possible outcomes.